SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's diseas...

Full description

Saved in:
Bibliographic Details
Main Authors Zhu, Xiuwen, Jones, Robert M, Buzard, Daniel J, Han, Sangdon, Stirn, Scott, Ullman, Brett, Kim, Sun Hee, Moody, Jeanne V, Lehmann, Juerg
Format Patent
LanguageEnglish
Published 09.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.
Bibliography:Application Number: US201816037309